dabigatran has been researched along with tosyllysine chloromethyl ketone in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (tosyllysine chloromethyl ketone) | Trials (tosyllysine chloromethyl ketone) | Recent Studies (post-2010) (tosyllysine chloromethyl ketone) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 402 | 0 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franco, FM; Han, Z; Harris, PK; Janetka, JW; Jarvis, CM; Jones, DE; Wildman, SA | 1 |
1 other study(ies) available for dabigatran and tosyllysine chloromethyl ketone
| Article | Year |
|---|---|
Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
Topics: Amidines; Antineoplastic Agents; Arginine; Benzamidines; Catalytic Domain; Drug Design; Enzyme Assays; Guanidines; High-Throughput Screening Assays; Humans; Kinetics; Molecular Docking Simulation; Neoplasm Proteins; Peptidomimetics; Phenylalanine; Piperazines; Protease Inhibitors; Recombinant Proteins; Serine Endopeptidases; Structure-Activity Relationship; Urea | 2015 |